CF
CLMT icon

Centaurus Financial’s Calumet Specialty Products CLMT Stock Holding History

Centaurus Financial’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-800
Closed -$6K – 787
2018
Q2 		$6K Buy
+800
New +$6.01K ﹤0.01% 1715

Other funds holding CLMT

DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centaurus Financial's CLMT Position: Q3 2018 in Review

Centaurus Financial sold out of Calumet Specialty Products (CLMT) in Q3 2018, closing a stake of 800 shares — an estimated $6K sold.

Centaurus Financial first reported a position in CLMT in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 68 funds tracked by Wall St. Rank hold CLMT as of Q3 2018.

  • Centaurus Financial reported no remaining Calumet Specialty Products position as of Q3 2018 after selling out during the quarter.
  • Centaurus Financial sold 800 Calumet Specialty Products shares in Q3 2018, an estimated $6K.
  • Centaurus Financial first reported a position in Calumet Specialty Products in Q2 2018 and held it in 1 quarter.
  • Centaurus Financial's Calumet Specialty Products position peaked at $6K in Q2 2018.
  • 68 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.